{
  "schemaVersion": "2.0.0",
  "identity": {
    "slug": "neuroxess",
    "name": {
      "value": "NeuroXess",
      "status": "unverified",
      "updatedAt": "2026-05-04"
    },
    "legalName": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "aliases": {
      "value": [
        "脑虎科技",
        "Brain Tiger"
      ],
      "status": "unverified",
      "updatedAt": "2026-05-04"
    },
    "tagline": {
      "value": "China's flexible-electrode brain interface.",
      "status": "unverified",
      "updatedAt": "2026-05-04"
    },
    "shortDescription": {
      "value": "Shanghai implantable-BCI startup developing a flexible-electrode array for invasive recording. Achieved China's first-in-human flexible-electrode BCI in 2025 with Huashan Hospital.",
      "status": "unverified",
      "updatedAt": "2026-05-04"
    },
    "longDescription": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "type": {
      "value": "private-startup",
      "status": "unverified",
      "updatedAt": "2026-05-04"
    },
    "focusAreas": {
      "value": [
        "medical-implant",
        "research-grade",
        "communication-aac"
      ],
      "status": "unverified",
      "updatedAt": "2026-05-04"
    },
    "parentCompanySlug": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "spinoutOf": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    },
    "founded": {
      "value": "2021",
      "status": "unverified",
      "updatedAt": "2026-05-04"
    },
    "defunct": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    }
  },
  "locations": {
    "headquartersCountry": {
      "value": "CN",
      "status": "unverified",
      "updatedAt": "2026-05-04"
    },
    "headquartersCity": {
      "value": "Shanghai",
      "status": "unverified",
      "updatedAt": "2026-05-04"
    },
    "addresses": {
      "value": [
        {
          "city": "Shanghai",
          "country": "CN",
          "isHeadquarters": true,
          "type": "hq"
        }
      ],
      "status": "unverified",
      "updatedAt": "2026-05-04"
    },
    "employeeCount": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    }
  },
  "people": {
    "founders": {
      "value": [
        {
          "name": "Tao Hu",
          "role": "Co-Founder, CEO",
          "isFounder": true,
          "isCurrent": true
        }
      ],
      "status": "unverified",
      "updatedAt": "2026-05-04"
    },
    "leadership": {
      "status": "unknown",
      "updatedAt": "2026-05-04"
    }
  },
  "products": {
    "deviceSlugs": {
      "value": [
        "neuroxess-bci"
      ],
      "status": "unverified",
      "updatedAt": "2026-05-04"
    },
    "flagshipDeviceSlug": {
      "value": "neuroxess-bci",
      "status": "unverified",
      "updatedAt": "2026-05-04"
    },
    "productLineCount": {
      "value": 1,
      "status": "unverified",
      "updatedAt": "2026-05-04"
    }
  },
  "history": {
    "notableMilestones": {
      "value": [
        {
          "date": "2021",
          "title": "NeuroXess founded in Shanghai"
        },
        {
          "date": "2025",
          "title": "First-in-human flexible-electrode BCI",
          "description": "Mandarin speech decoding in a tetraplegic patient at Huashan Hospital, Fudan University."
        }
      ],
      "status": "unverified",
      "updatedAt": "2026-05-04"
    }
  },
  "editorial": {
    "reputationNotes": "Among the most advanced of China's implantable-BCI startups; positioned alongside StairMed and others as domestic competition to Neuralink, with state-backed clinical-trial pipeline.",
    "controversies": []
  },
  "provenance": {
    "sources": [
      {
        "label": "Reuters — NeuroXess first-in-human",
        "url": "https://www.reuters.com/technology"
      }
    ]
  }
}